查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1552858

活体生物治疗市场、治疗领域和给药途径 - 全球产业分析、规模、份额、成长、趋势和预测，2024-2034 年

Live Biotherapeutics Market, Therapeutic Area and Route of Administration - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
出版日期: | 出版商: Transparency Market Research | 英文 141 Pages | 商品交期: 2-10个工作天内

价格

活体生物治疗市场 - 报告范围

TMR 关于全球活体生物治疗市场的报告研究了过去以及当前的成长趋势和机会，以获得 2024 年至 2034 年预测期内市场指标的宝贵见解。年期间，考虑2024年为基准年，2034年为预测年。该报告也提供了2024年至2034年全球活体生物治疗市场的年复合成长率（CAGR%）。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了采访。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解活体生物治疗市场。

市场概况
2023年市场价值 1.055 亿美元
2034 年市场价值 4.229 亿美元
复合年增长率 14%

该报告深入研究了全球活体生物治疗市场的竞争格局。全球活体生物治疗市场的主要参与者已被确定，并且每一位参与者都已根据各种属性进行了分析。公司概况、财务状况、最新发展和 SWOT 是本报告中介绍的全球活体生物治疗市场参与者的属性。

目录

第一章：前言

第 2 章：假设与研究方法

第 3 章：执行摘要：全球市场

第 4 章：市场概述

  • 介绍
  • 概述
  • 市场动态
  • 2020-2034年全球市场分析与预测

第 5 章：主要见解

  • 管道分析
  • 艰难梭菌感染的流行病学
  • 关于美国艰难梭菌感染负担趋势的见解
  • 波特五力分析

第 6 章：全球市场分析与预测：按治疗领域

  • 简介与定义
  • 主要发现/进展
  • 2020-2034 年治疗领域市场价值预测
    • 胃肠道疾病
    • 代谢紊乱
    • 皮肤科疾病
    • 其他的
  • 按治疗领域分類的市场吸引力

第 7 章：全球市场分析与预测：按给药途径

  • 简介与定义
  • 主要发现/进展
  • 2020-2034 年按给药途径分類的市场价值预测
    • 口服
    • 直肠
    • 其他（专题等）
  • 按给药途径分類的市场吸引力

第 8 章：全球市场分析与预测：按配销通路

  • 简介与定义
  • 主要发现/进展
  • 2020-2034 年按配销通路分類的市场价值预测
    • 医院药房
    • 零售药局
    • 网路药局
  • 按配销通路分類的市场吸引力

第 9 章：全球市场分析与预测：按地区

  • 主要发现
  • 各地区市场价值预测
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 按国家/地区分類的市场吸引力

第 10 章：北美市场分析与预测

  • 我们
  • 加拿大

第 11 章：欧洲市场分析与预测

  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 欧洲其他地区

第 12 章：亚太市场分析与预测

  • 中国
  • 印度
  • 日本
  • 澳洲和纽西兰
  • 亚太地区其他地区

第 13 章：拉丁美洲市场分析与预测

  • 巴西
  • 墨西哥
  • 拉丁美洲其他地区

第 14 章：中东和非洲市场分析与预测

  • 海湾合作委员会
  • 南非
  • 中东和非洲其他地区

第15章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 公司市占率分析 (2023)
  • 公司简介
    • Ferring Pharmaceuticals
    • Seres Therapeutics
    • Rebiotix Inc.
    • 4D Pharma
    • Finch Therapeutics
    • Vedanta Biosciences
    • Synthetic Biologics
    • MaaT Pharma
    • Enterome
    • Second Genome
Product Code: TMRGL86353

Live Biotherapeutics Market - Scope of Report

TMR's report on the global live biotherapeutics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global live biotherapeutics market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global live biotherapeutics market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the live biotherapeutics market.

Market Snapshot
Market Value in 2023US$ 105.5 Mn
Market Value in 2034US$ 422.9 Mn
CAGR14%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global live biotherapeutics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global live biotherapeutics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global live biotherapeutics market.

The report delves into the competitive landscape of the global live biotherapeutics market. Key players operating in the global live biotherapeutics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global live biotherapeutics market profiled in this report.

Key Questions Answered in Global live biotherapeutics Market Report:

  • What is the sales/revenue generated by live biotherapeutics across all regions during the forecast period?
  • What are the opportunities in the global live biotherapeutics market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Live Biotherapeutics Market - Research Objectives and Research Approach

The comprehensive report on the global live biotherapeutics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global live biotherapeutics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global live biotherapeutics market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Live Biotherapeutics Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Live Biotherapeutics Market Analysis and Forecast, 2020-2034

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Epidemiology of Clostridium Difficile Infection
  • 5.3. Insights on Trends in the U.S. Burden of Clostridioides Difficile Infection
  • 5.4. Porters' Five Forces Analysis

6. Global Live Biotherapeutics Market Analysis and Forecast, By Therapeutic Area

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Therapeutic Area, 2020-2034
    • 6.3.1. Gastrointestinal Disorders
    • 6.3.2. Metabolic Disorders
    • 6.3.3. Dermatological Diseases
    • 6.3.4. Others
  • 6.4. Market Attractiveness By Therapeutic Area

7. Global Live Biotherapeutics Market Analysis and Forecast, By Route of Administration

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Route of Administration, 2020-2034
    • 7.3.1. Oral
    • 7.3.2. Rectal
    • 7.3.3. Others (Topical etc.)
  • 7.4. Market Attractiveness By Route of Administration

8. Global Live Biotherapeutics Market Analysis and Forecast, By Distribution Channel

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By Distribution Channel, 2020-2034
    • 8.3.1. Hospital Pharmacies
    • 8.3.2. Retail Pharmacies
    • 8.3.3. Online Pharmacies
  • 8.4. Market Attractiveness By Distribution Channel

9. Global Live Biotherapeutics Market Analysis and Forecast, By Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast By Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness By Country/Region

10. North America Live Biotherapeutics Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast By Therapeutic Area, 2020-2034
    • 10.2.1. Gastrointestinal Disorders
    • 10.2.2. Metabolic Disorders
    • 10.2.3. Dermatological Diseases
    • 10.2.4. Others
  • 10.3. Market Value Forecast By Route of Administration, 2020-2034
    • 10.3.1. Oral
    • 10.3.2. Rectal
    • 10.3.3. Others (Topical etc.)
  • 10.4. Market Value Forecast By Distribution Channel, 2020-2034
    • 10.4.1. Hospital Pharmacies
    • 10.4.2. Retail Pharmacies
    • 10.4.3. Online Pharmacies
  • 10.5. Market Value Forecast By Country, 2020-2034
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Therapeutic Area
    • 10.6.2. By Route of Administration
    • 10.6.3. By Distribution Channel
    • 10.6.4. By Country

11. Europe Live Biotherapeutics Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Therapeutic Area, 2030-2034
    • 11.2.1. Gastrointestinal Disorders
    • 11.2.2. Metabolic Disorders
    • 11.2.3. Dermatological Diseases
    • 11.2.4. Others
  • 11.3. Market Value Forecast By Route of Administration, 2030-2034
    • 11.3.1. Oral
    • 11.3.2. Rectal
    • 11.3.3. Others (Topical etc.)
  • 11.4. Market Value Forecast By Distribution Channel, 2030-2034
    • 11.4.1. Hospital Pharmacies
    • 11.4.2. Retail Pharmacies
    • 11.4.3. Online Pharmacies
  • 11.5. Market Value Forecast By Country, 2030-2034
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Therapeutic Area
    • 11.6.2. By Route of Administration
    • 11.6.3. By Distribution Channel
    • 11.6.4. By Country

12. Asia Pacific Live Biotherapeutics Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Therapeutic Area, 2031-2034
    • 12.2.1. Gastrointestinal Disorders
    • 12.2.2. Metabolic Disorders
    • 12.2.3. Dermatological Diseases
    • 12.2.4. Others
  • 12.3. Market Value Forecast By Route of Administration, 2031-2034
    • 12.3.1. Oral
    • 12.3.2. Rectal
    • 12.3.3. Others (Topical etc.)
  • 12.4. Market Value Forecast By Distribution Channel, 2031-2034
    • 12.4.1. Hospital Pharmacies
    • 12.4.2. Retail Pharmacies
    • 12.4.3. Online Pharmacies
  • 12.5. Market Value Forecast By Country, 2031-2034
    • 12.5.1. China
    • 12.5.2. India
    • 12.5.3. Japan
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Therapeutic Area
    • 12.6.2. By Route of Administration
    • 12.6.3. By Distribution Channel
    • 12.6.4. By Country

13. Latin America Live Biotherapeutics Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Therapeutic Area, 2032-2034
    • 13.2.1. Gastrointestinal Disorders
    • 13.2.2. Metabolic Disorders
    • 13.2.3. Dermatological Diseases
    • 13.2.4. Others
  • 13.3. Market Value Forecast By Route of Administration, 2032-2034
    • 13.3.1. Oral
    • 13.3.2. Rectal
    • 13.3.3. Others (Topical etc.)
  • 13.4. Market Value Forecast By Distribution Channel, 2032-2034
    • 13.4.1. Hospital Pharmacies
    • 13.4.2. Retail Pharmacies
    • 13.4.3. Online Pharmacies
  • 13.5. Market Value Forecast By Country, 2032-2034
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Therapeutic Area
    • 13.6.2. By Route of Administration
    • 13.6.3. By Distribution Channel
    • 13.6.4. By Country

14. Middle East & Africa Live Biotherapeutics Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Therapeutic Area, 2032-2034
    • 14.2.1. Gastrointestinal Disorders
    • 14.2.2. Metabolic Disorders
    • 14.2.3. Dermatological Diseases
    • 14.2.4. Others
  • 14.3. Market Value Forecast By Route of Administration, 2032-2034
    • 14.3.1. Oral
    • 14.3.2. Rectal
    • 14.3.3. Others (Topical etc.)
  • 14.4. Market Value Forecast By Distribution Channel, 2032-2034
    • 14.4.1. Hospital Pharmacies
    • 14.4.2. Retail Pharmacies
    • 14.4.3. Online Pharmacies
  • 14.5. Market Value Forecast By Country, 2032-2034
    • 14.5.1. GCC
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Therapeutic Area
    • 14.6.2. By Route of Administration
    • 14.6.3. By Distribution Channel
    • 14.6.4. By Country

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 15.2. Market Share Analysis By Company (2023)
  • 15.3. Company Profiles
    • 15.3.1. Ferring Pharmaceuticals
      • 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. Financial Overview
      • 15.3.1.4. SWOT Analysis
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Seres Therapeutics
      • 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. Financial Overview
      • 15.3.2.4. SWOT Analysis
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Rebiotix Inc.
      • 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. Financial Overview
      • 15.3.3.4. SWOT Analysis
      • 15.3.3.5. Strategic Overview
    • 15.3.4. 4D Pharma
      • 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. Financial Overview
      • 15.3.4.4. SWOT Analysis
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Finch Therapeutics
      • 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. Financial Overview
      • 15.3.5.4. SWOT Analysis
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Vedanta Biosciences
      • 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. Financial Overview
      • 15.3.6.4. SWOT Analysis
      • 15.3.6.5. Strategic Overview
    • 15.3.7. Synthetic Biologics
      • 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. Financial Overview
      • 15.3.7.4. SWOT Analysis
      • 15.3.7.5. Strategic Overview
    • 15.3.8. MaaT Pharma
      • 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. Financial Overview
      • 15.3.8.4. SWOT Analysis
    • 15.3.9. Enterome
      • 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. Financial Overview
      • 15.3.9.4. SWOT Analysis
    • 15.3.10. Second Genome
      • 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.10.2. Product Portfolio
      • 15.3.10.3. Financial Overview
      • 15.3.10.4. SWOT Analysis

List of Tables

  • Table 01: Global Live Biotherapeutics Market Value (US$ Mn) Forecast, by Therapeutic Area, 2020-2034
  • Table 02: Global Live Biotherapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2020-2034
  • Table 03: Global Live Biotherapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 04: Global Live Biotherapeutics Market Value (US$ Mn) Forecast, by Region, 2020-2034
  • Table 05: North America Live Biotherapeutics Market Value (US$ Mn) Forecast, by Country, 2020-2034
  • Table 06: North America Live Biotherapeutics Market Value (US$ Mn) Forecast, by Therapeutic Area, 2020-2034
  • Table 07: North America Live Biotherapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2020-2034
  • Table 08: North America Live Biotherapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 09: Europe Live Biotherapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2030-2034
  • Table 10: Europe Live Biotherapeutics Market Value (US$ Mn) Forecast, by Therapeutic Area, 2030-2034
  • Table 11: Europe Live Biotherapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2030-2034
  • Table 12: Europe Live Biotherapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2030-2034
  • Table 13: Asia Pacific Live Biotherapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2031-2034
  • Table 14: Asia Pacific Live Biotherapeutics Market Value (US$ Mn) Forecast, by Therapeutic Area, 2031-2034
  • Table 15: Asia Pacific Live Biotherapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2031-2034
  • Table 16: Asia Pacific Live Biotherapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2031-2034
  • Table 17: Latin America Live Biotherapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2032-2034
  • Table 18: Latin America Live Biotherapeutics Market Value (US$ Mn) Forecast, by Therapeutic Area, 2032-2034
  • Table 19: Latin America Live Biotherapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2032-2034
  • Table 20: Latin America Live Biotherapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2032-2034
  • Table 21: Middle East & Africa Live Biotherapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2032-2034
  • Table 22: Middle East & Africa Live Biotherapeutics Market Value (US$ Mn) Forecast, by Therapeutic Area, 2032-2034
  • Table 23: Middle East & Africa Live Biotherapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2032-2034
  • Table 24: Middle East & Africa Live Biotherapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2032-2034

List of Figures

  • Figure 01: Global Live Biotherapeutics Market Value (US$ Mn) Forecast, 2020-2034
  • Figure 02: Global Live Biotherapeutics Market Value Share, by Therapeutic Area, 2023
  • Figure 03: Global Live Biotherapeutics Market Value Share, by Route of Administration, 2023
  • Figure 04: Global Live Biotherapeutics Market Value Share, by Distribution Channel, 2023
  • Figure 05: Global Live Biotherapeutics Market Value (US$ Mn) Share Analysis, by Therapeutic Area, 2023 and 2034
  • Figure 06: Global Live Biotherapeutics Market Share Analysis, by Therapeutic Area, 2022
  • Figure 07: Global Live Biotherapeutics Market Share Analysis, by Therapeutic Area, 2031
  • Figure 08: Global Live Biotherapeutics Market Attractiveness Analysis, by Therapeutic Area, 2024-2034
  • Figure 09: Global Live Biotherapeutics Market Value (US$ Mn) Share Analysis, by Route of Administration, 2023 and 2034
  • Figure 10: Global Live Biotherapeutics Market Share Analysis, by Route of Administration, 2022
  • Figure 11: Global Live Biotherapeutics Market Share Analysis, by Route of Administration, 2031
  • Figure 12: Global Live Biotherapeutics Market Attractiveness Analysis, by Route of Administration, 2024-2034
  • Figure 13: Global Live Biotherapeutics Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 14: Global Live Biotherapeutics Market Share Analysis, by Distribution Channel, 2022
  • Figure 15: Global Live Biotherapeutics Market Share Analysis, by Distribution Channel, 2031
  • Figure 16: Global Live Biotherapeutics Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 17: Global Live Biotherapeutics Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 18: Global Live Biotherapeutics Market Share Analysis, by Region, 2022
  • Figure 19: Global Live Biotherapeutics Market Share Analysis, by Region, 2031
  • Figure 20: Global Live Biotherapeutics Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 21: North America Live Biotherapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 22: North America Live Biotherapeutics Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 23: North America Live Biotherapeutics Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 24: North America Live Biotherapeutics Market Value (US$ Mn) Share Analysis, by Therapeutic Area, 2023 and 2034
  • Figure 25: North America Live Biotherapeutics Market Attractiveness Analysis, by Therapeutic Area, 2024-2034
  • Figure 26: North America Live Biotherapeutics Market Value (US$ Mn) Share Analysis, by Route of Administration, 2023 and 2034
  • Figure 27: North America Live Biotherapeutics Market Attractiveness Analysis, by Route of Administration, 2024-2034
  • Figure 28: North America Live Biotherapeutics Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 29: North America Live Biotherapeutics Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 30: Europe Live Biotherapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2030-2034
  • Figure 31: Europe Live Biotherapeutics Market Value Share Analysis, by Country/Sub-region, 2030 and 2034
  • Figure 32: Europe Live Biotherapeutics Market Attractiveness Analysis, by Country/Sub-region, 2030-2034
  • Figure 33: Europe Live Biotherapeutics Market Value (US$ Mn) Share Analysis, by Therapeutic Area, 2030 and 2034
  • Figure 34: Europe Live Biotherapeutics Market Attractiveness Analysis, by Therapeutic Area, 2030-2034
  • Figure 35: Europe Live Biotherapeutics Market Value (US$ Mn) Share Analysis, by Route of Administration, 2030 and 2034
  • Figure 36: Europe Live Biotherapeutics Market Attractiveness Analysis, by Route of Administration, 2030-2034
  • Figure 37: Europe Live Biotherapeutics Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2030 and 2034
  • Figure 38: Europe Live Biotherapeutics Market Attractiveness Analysis, by Distribution Channel, 2030-2034
  • Figure 39: Asia Pacific Live Biotherapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2031-2034
  • Figure 40: Asia Pacific Live Biotherapeutics Market Value Share Analysis, by Country/Sub-region, 2031 and 2034
  • Figure 41: Asia Pacific Live Biotherapeutics Market Attractiveness Analysis, by Country/Sub-region, 2031-2034
  • Figure 42: Asia Pacific Live Biotherapeutics Market Value (US$ Mn) Share Analysis, by Therapeutic Area, 2031 and 2034
  • Figure 43: Asia Pacific Live Biotherapeutics Market Attractiveness Analysis, by Therapeutic Area, 2031-2034
  • Figure 44: Asia Pacific Live Biotherapeutics Market Value (US$ Mn) Share Analysis, by Route of Administration, 2031 and 2034
  • Figure 45: Asia Pacific Live Biotherapeutics Market Attractiveness Analysis, by Route of Administration, 2031-2034
  • Figure 46: Asia Pacific Live Biotherapeutics Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2031 and 2034
  • Figure 47: Asia Pacific Live Biotherapeutics Market Attractiveness Analysis, by Distribution Channel, 2031-2034
  • Figure 48: Latin America Live Biotherapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2032-2034
  • Figure 49: Latin America Live Biotherapeutics Market Value Share Analysis, by Country/Sub-region, 2032 and 2034
  • Figure 50: Latin America Live Biotherapeutics Market Attractiveness Analysis, by Country/Sub-region, 2032-2034
  • Figure 51: Latin America Live Biotherapeutics Market Value (US$ Mn) Share Analysis, by Therapeutic Area, 2032 and 2034
  • Figure 52: Latin America Live Biotherapeutics Market Attractiveness Analysis, by Therapeutic Area, 2032-2034
  • Figure 53: Latin America Live Biotherapeutics Market Value (US$ Mn) Share Analysis, by Route of Administration, 2032 and 2034
  • Figure 54: Latin America Live Biotherapeutics Market Attractiveness Analysis, by Route of Administration, 2032-2034
  • Figure 55: Latin America Live Biotherapeutics Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2032 and 2034
  • Figure 56: Latin America Live Biotherapeutics Market Attractiveness Analysis, by Distribution Channel, 2032-2034
  • Figure 57: Middle East & Africa Live Biotherapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2032-2034
  • Figure 58: Middle East & Africa Live Biotherapeutics Market Value Share Analysis, by Country/Sub-region, 2032 and 2034
  • Figure 59: Middle East & Africa Live Biotherapeutics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 60: Middle East & Africa Live Biotherapeutics Market Value (US$ Mn) Share Analysis, by Therapeutic Area, 2032 and 2034
  • Figure 61: Middle East & Africa Live Biotherapeutics Market Attractiveness Analysis, by Therapeutic Area, 2032-2034
  • Figure 62: Middle East & Africa Live Biotherapeutics Market Value (US$ Mn) Share Analysis, by Route of Administration, 2032 and 2034
  • Figure 63: Middle East & Africa Live Biotherapeutics Market Attractiveness Analysis, by Route of Administration, 2032-2034
  • Figure 64: Middle East & Africa Live Biotherapeutics Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2032 and 2034
  • Figure 65: Middle East & Africa Live Biotherapeutics Market Attractiveness Analysis, by Distribution Channel, 2032-2034